Following news that Insulet has named Wayde McMillan as its new CFO, Piper Jaffray analyst JP McKim said that while outgoing CFO Michael Levitz will "certainly be missed," as he has been "crucial" to the company's profitable growth over the last four years, he feels that the company is in "good hands" with McMillan, who brings 20 years of relevant experience as well as M&A experience. McKim, who reiterates an Overweight rating and $106 price target on Insulet shares, tells investors in a research note that "now is as good a time as any" for a CFO transition.